Galderma Group AG (GALD.SW)

Swiss · Healthcare · Drug Manufacturers - Specialty & Generic
182.85 CHF-1.00%As of 2026-11-22 · CHF
Last session low 180.95 CHFLast session high 184.80 CHF
52-week low 136.30 CHF52-week high 197.00 CHF
Market cap (USD)
$50.79B
Sector
Healthcare
P/E (TTM)
63.1x
Dividend yield
0.19%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CHF.

IndicatorValueReading
RSI (14)46.1In the neutral range (30 to 70)
MACD (12, 26, 9)2.70Below its signal line (4.63); histogram -1.93
Bollinger %B (20, 2)-1%Below the lower band (182.97 to 197.28)
SMA 20190.13Price is 3.8% below
SMA 50175.58Price is 4.1% above
SMA 200165.89Price is 10.2% above
ATR (20)2.49% of priceAverage true range per day
52-week position77%In the upper part of the 136.30 to 197.00 range

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.

Latest fiscal yearEnded 2025-12-31: revenue of $5.24B and an operating margin of 16.7%.

More in Drug Manufacturers - Specialty & Generic